Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Apr, 7 2025
May, 9 2024
Oct, 28 2024
Dec, 19 2024
May, 27 2026